Table 1.
Baseline clinical and biochemical profiles of patients with hepatic encephalopathy
| n = 30 | |
|---|---|
| Age, years | 65.5 ± 11.9 |
| Gender, male/female | 19/11 |
| ALBI score | −1.92 ± 0.38 |
| HCC | 16 |
| Etiology, HBV/HCV/NASH/alcohol/others | 3/11/6/6/4 |
| Alb, g/dL | 3.33 ± 0.36 |
| Total bilirubin, mg/dL | 1.57 ± 0.83 |
| AST, IU/L | 42.0 ± 16.7 |
| ALT, IU/L | 26.5 ± 12.7 |
| ALP, U/L | 377.6 ± 140.4 |
| NH3, μg/dL | 100.5 ± 40.1 |
| BUN, mg/dL | 19.1 ± 12.0 |
| Creatinine, mg/dL | 0.92 ± 0.30 |
| CRP, mg/dL | 0.62 ± 0.95 |
| White cell counts, /μL | 4482 ± 1948 |
| Hemoglobin, g/dL | 11.1 ± 2.0 |
| Platelets, ×103/μL | 128.9 ± 74.7 |
| Prothrombin time, % | 69.7 ± 17.6 |
| 10‐7G, U/L | 23.3 ± 37.0 |
| Enterococcus faecalis CPS antibody, titer | 0.016 ± 0.006 |
| Mac‐2 bp, ng/mL | 1984 ± 890 |
Data are presented as number of patients, mean ± SD, or median (minimum–maximum).
Alb, albumin; ALBI, albumin–bilirubin; ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate transaminase; BUN, blood urea nitrogen; CPS, capsular polysaccharide; CRP, C‐reactive protein; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; Mac‐2 bp, Mac‐2 binding protein; NASH, non‐alcoholic steatohepatitis; NH3, ammonia.